Pfizer and Merck KGaA commence late-stage trials of avelumab in gastric cancers
The immunotherapy avelumab will be tested in gastric cancer.
The immunotherapy avelumab will be tested in gastric cancer.
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE